PROCEPT BioRobotics
Stock Forecast, Prediction & Price Target
PROCEPT BioRobotics (PRCT) stock Price Target by analysts
$105
Potential upside: 165.35%
PROCEPT BioRobotics price prediction
What is PROCEPT BioRobotics stock analysts` prediction?
PROCEPT BioRobotics stock forecast: Based on 2 Wall Street analysts` predicted price targets for PROCEPT BioRobotics in the last 3 months, the avarage price target is $105, with a high forecast of $NaN. The average price target represents a 165.35% change from the last price of $39.57.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
PROCEPT BioRobotics stock Price Target by analysts
Full breakdown of analysts given PROCEPT BioRobotics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Patrick Wood Morgan Stanley | 0% 0/1 | 9 months ago | $105 165.35% upside | $94.93 | StreetInsider | Previous targets (0) |
Richard Newitter Truist Financial | 0% 0/4 | 10 months ago | $105 165.35% upside | $96.24 | StreetInsider | Previous targets (3) |
Richard Newitter Truist Financial | 0% 0/4 | about 1 year ago | $95 140.08% upside | $79 | TheFly | Previous targets (3) |
Richard Newitter Truist Financial | 0% 0/4 | about 1 year ago | $79 99.64% upside | $68.9 | TheFly | Previous targets (3) |
Matt O'Brien Piper Sandler | 0% 0/1 | over 1 year ago | $75 89.53% upside | $64.31 | StreetInsider | Previous targets (0) |
Richard Newitter Truist Financial | 0% 0/4 | over 1 year ago | $72 81.95% upside | $60.61 | TheFly | Previous targets (3) |
Nathan Treybeck Wells Fargo | 100% 1/1 | about 3 years ago | $49 23.83% upside | $40.38 | TheFly | Previous targets (0) |
PROCEPT BioRobotics Financial Estimates
PROCEPT BioRobotics Revenue Estimates
PROCEPT BioRobotics EBITDA Estimates
PROCEPT BioRobotics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $34.47M N/A | $75.01M 117.60% | $136.19M 81.55% | Avg: $299.60M Low: $290.67M High: $308.00M avg. 119.99% | Avg: $390.39M Low: $377.64M High: $398.96M avg. 30.29% | Avg: $500.54M Low: $484.19M High: $511.54M avg. 28.21% | Avg: $558.05M Low: $539.82M High: $570.31M avg. 11.48% |
Net Income
% change YoY
| $-62.38M N/A | $-93.58M -50.01% | $-105.89M -13.15% | Avg: $-76.07M Low: $-79.86M High: $-54.81M avg. 28.15% | Avg: $-42.08M Low: $-54.81M High: $-19.84M avg. 44.68% | Avg: $-12.75M Low: $-13.12M High: $-12.21M avg. 69.68% | Avg: $12.99M Low: $12.44M High: $13.36M avg. 201.85% |
EBITDA
% change YoY
| $-54.04M N/A | $-78.71M -45.64% | $-98.09M -24.62% | Avg: $-286.04M Low: $-294.05M High: $-277.51M avg. -191.60% | Avg: $-372.71M Low: $-380.90M High: $-360.54M avg. -30.29% | Avg: $-477.88M Low: $-488.38M High: $-462.27M avg. -28.21% | Avg: $-532.78M Low: $-544.49M High: $-515.38M avg. -11.48% |
EPS
% change YoY
| -$1.43 N/A | -$2.11 -47.55% | -$2.24 -6.16% | Avg: -$1.47 Low: -$1.69 High: -$1.16 avg. 34.48% | Avg: -$0.78 Low: -$1.16 High: -$0.42 avg. 46.67% | Avg: -$0.27 Low: -$0.28 High: -$0.26 avg. 65.49% | Avg: $0.28 Low: $0.26 High: $0.28 avg. 201.85% |
Operating Expenses
% change YoY
| $70.02M N/A | $117.80M 68.22% | $180.21M 52.97% | Avg: $729.71M Low: $707.95M High: $750.15M avg. 304.90% | Avg: $950.81M Low: $919.76M High: $971.70M avg. 30.29% | Avg: $1.21B Low: $1.17B High: $1.24B avg. 28.21% | Avg: $1.35B Low: $1.31B High: $1.38B avg. 11.48% |
FAQ
What is PROCEPT BioRobotics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 86.09% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -79.86M, average is -76.07M and high is -54.81M.
What is PROCEPT BioRobotics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 47.49% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $290.67M, average is $299.60M and high is $308.00M.
What is PROCEPT BioRobotics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 87.12% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$1.69, average is -$1.47 and high is $-1.16.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering PROCEPT BioRobotics stock. The most successful analyst is Patrick Wood.